The Antimicrobial and Antibiofilm Abilities of Fish Oil Derived Polyunsaturated Fatty Acids and Manuka Honey.
Jenna ClareMartin R LindleyElizabeth RatcliffePublished in: Microorganisms (2024)
Both honey and fish oil have been historically used in medicine and identified as having antimicrobial properties. Although analyses of the substances have identified different components within them, it is not fully understood how these components interact and contribute to the observed effect. With the increase in multi-drug resistant strains of bacteria found in infections, new treatment options are needed. This study aimed to assess the antimicrobial abilities of fish oil components, including docosahexaenoic acid (DHA), eicosapentaenoic acid (EPA), and derived resolvins (RvE1, RvD2, and RvD3), as well as two varieties of manuka honey, against a panel of medically relevant microorganisms and antimicrobial resistant organisms, such as Methicillin Resistant Staphylococcus aureus (MRSA) and carbapenem-resistant Escherichia coli . Minimum inhibitory concentrations (MIC) and minimum bactericidal concentrations (MBC) were identified; further minimum biofilm eradication concentrations (MBEC) were investigated for responsive organisms, including S. aureus , E. coli , Staphylococcus epidermidis , Klebsiella pneumoniae , and Pseudomonas aeruginosa. Concurrent with the existing literature, manuka honey was found to be a broad-spectrum antimicrobial with varied potency according to methylglyoxal content. DHA and EPA were both effective against Gram-positive and negative bacteria, but some drug-resistant strains or pathogens were not protected by a capsule. Only E. coli was inhibited by the resolvins.
Keyphrases
- staphylococcus aureus
- drug resistant
- escherichia coli
- multidrug resistant
- gram negative
- methicillin resistant staphylococcus aureus
- biofilm formation
- klebsiella pneumoniae
- acinetobacter baumannii
- pseudomonas aeruginosa
- fatty acid
- cystic fibrosis
- squamous cell carcinoma
- high resolution
- candida albicans
- helicobacter pylori infection
- cancer therapy
- helicobacter pylori